Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
In addition to activating T and B lymphocytes, interleukin 1 (IL-1) induces several hematologic and metabolic changes typical of host responses to infection and injury. We now report a new biological property, namely, the induction of hypotension. Rabbits given a single intravenous injection of recombinant human IL-1-beta (5 micrograms/kg) rapidly developed decreased systemic arterial pressure, which reached the lowest levels after 50-60 min and slowly returned to pre-IL-1 values after 3 h. Associated with the hypotension, systemic vascular resistance and central venous pressure fell, while cardiac output and heart rate increased. These responses were prevented by ibuprofen given 15 min before the IL-1. A bolus injection of IL-1 followed by a 2-h infusion sustained the hypotension and was associated with leukopenia and thrombocytopenia. Ibuprofen given at the mid-point of the infusion reversed the changes in all hemodynamic parameters, but had no effect on the leukopenia or thrombocytopenia. Tumor necrosis factor (TNF) also induced a shock-like state in rabbits. When the dose of IL-1 or TNF was reduced to 1 microgram/kg, no hemodynamic changes were observed; however, the combination of these low doses of both cytokines resulted in a profound shock-like state including histological evidence of severe pulmonary edema and hemorrhage. Pretreatment with ibuprofen prevented the hemodynamic, leukocyte, and platelet changes induced by the low-dose cytokine combination, and ameliorated the pulmonary tissue damage. These results demonstrate that IL-1, like TNF, possesses the ability to induce hemodynamic and hematological changes typical of septic shock, and that the combination of IL-1 and TNF is more potent than either agent alone. These effects seem to require cyclooxygenase products, and suggest that intravenous cyclooxygenase inhibitors may be of therapeutic value in patients with IL-1/TNF-mediated shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Beutler, B., Milsark, I. W., & Cerami, A. C. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,352
Cachectin and tumour necrosis factor as two sides of the same biological coin
Beutler, B., & Cerami, A. (1986) · Nature · doi:10.1038/320584a0 · Cited by 1,647
Immunoregulatory Feedback Between Interleukin-1 and Glucocorticoid Hormones
Besedovsky, H., del Rey, A., Sorkin, E., & Dinarello, C. A. (1986) · Science · doi:10.1126/science.3014662 · Cited by 1,519
Self-citationTumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A., & O'Connor, J. V. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1433 · Cited by 1,472
Self-citationBevilacqua, M. P., Pober, J. S., Wheeler, M. E., Cotran, R. S., & Gimbrone, M. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112200 · Cited by 1,104
Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.
Auron, P. E., Webb, A. C., Rosenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., & Dinarello, C. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7907 · Cited by 1,042
Self-citationCloning and expression of murine interleukin-1 cDNA in Escherichia coli
Lomedico, P. T., Gubler, U., Hellmann, C. P., Dukovich, M., Giri, J. G., Pan, Y.-C. E., Collier, K., Semionow, R., Chua, A. O., & Mizel, S. B. (1984) · Nature · doi:10.1038/312458a0 · Cited by 816
Dinarello, C. A., Ikejima, T., Warner, S. J. C., Orencole, S. F., Lonnemann, G., Cannon, J. G., & Libby, P. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.6.1902 · Cited by 537
Self-citationLibby, P., Ordovás, J. M., Auger, K. R., Robbins, A. H., Birinyi, L. K., & Dinarello, C. A. (1986) · PubMed Central · Cited by 494
Self-citationSleep-promoting effects of endogenous pyrogen (interleukin-1)
Krueger, J. M., Walter, J., Dinarello, C. A., Wolff, S. M., & Chedid, L. (1984) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1984.246.6.r994 · Cited by 455
Self-citationCachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.
Tracey, K. J., Lowry, S. F., Fahey, T. J., Albert, J. D., Fong, Y., HESSE, D. G., Beutler, B., Manogue, K. R., Calvano, S. E., & Hu, W. M. (1987) · PubMed · Cited by 429
Multiple biological activities of human recombinant interleukin 1.
Dinarello, C. A., Cannon, J. G., Mier, J. W., Bernheim, H. A., LoPreste, G., Lynn, D. L., Love, R. N., Webb, A. C., Auron, P. E., & Reuben, R. C. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112495 · Cited by 368
Self-citationPlatelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.
Chang, S. W., Feddersen, C. O., Henson, P. M., & Voelkel, N. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112980 · Cited by 358
Increased Plasma Interleukin-1 Activity in Women After Ovulation
Cannon, J. G., & Dinarello, C. A. (1985) · Science · doi:10.1126/science.3871966 · Cited by 340
Self-citationEndogenous Pyrogen Activity in Human Plasma After Exercise
Cannon, J. G., & Kluger, M. J. (1983) · Science · doi:10.1126/science.6836306 · Cited by 249
Elias, J. A., Gustilo, K., Baeder, W., & Freundlich, B. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.11.3812 · Cited by 231
Movat, H. Z., Burrowes, C. E., Cybulsky, M. I., & Dinarello, C. A. (1987) · PubMed Central · Cited by 217
Self-citationClinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer.
Chapman, P. B., Lester, T. J., Casper, E. S., Gabrilove, J. L., Wong, G. Y., Kempin, S. J., Gold, P. J., Welt, S., Warren, R. S., & Starnes, H. F. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.12.1942 · Cited by 214
Suppression of fever after lesions of the anteroventral third ventricle in guinea pigs
Blatteis, C. M., Bealer, S. L., Hunter, W. S., Llanos, J.-Q., Ahokas, R. A., & Mashburn, T. A. (1983) · Brain Research Bulletin · doi:10.1016/0361-9230(83)90124-7 · Cited by 213
Recombinant human interleukin 1 alpha: purification and biological characterization.
Gubler, U., Chua, A. O., Stern, A. S., Hellmann, C. P., Vitek, M. P., Dechiara, T. M., Benjamin, W. R., Collier, K. J., Dukovich, M., Familletti, P. C., et al. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2492 · Cited by 213
Biological Effects of Bacterial Endotoxins in Man
Wolff, S. M. (1973) · Journal of Infectious Diseases · doi:10.1093/infdis/128.supplement_1.s259 · Cited by 212
C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma.
Okusawa, S., Dinarello, C. A., Yancey, K. B., Endres, S., Lawley, T. J., Frank, M. M., Burke, J. F., & Gelfand, J. A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.8.2635 · Cited by 193
Self-citationIkejima, T., Dinarello, C. A., Gill, D. M., & Wolff, S. M. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111334 · Cited by 154
Self-citationStitt, J. T. (1985) · The Journal of Physiology · doi:10.1113/jphysiol.1985.sp015872 · Cited by 153
Albrightson, C. R., Baenziger, N. L., & Needleman, P. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.3.1872 · Cited by 140
Dinarello, C. A. (1986) · The Year in immunology · Cited by 131
Self-citationIbuprofen in canine endotoxin shock.
Jacobs, E. R., Soulsby, M., Bone, R. C., Wilson, F. J., & Hiller, F. C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110645 · Cited by 129
Inhibition of Prostaglandin Synthesis Restores Normal Hemodynamics in Canine Hyperdynamic Sepsis
Fink, M. P., MacVittie, T. J., & Casey, L. C. (1984) · Annals of Surgery · doi:10.1097/00000658-198411000-00011 · Cited by 84
Gj, S., Burchard, K. W., Williams, J. J., D'Arezzo, A., & Yellin, S. A. (1986) · Journal of Critical Care · doi:10.1016/s0883-9441(86)80020-x · Cited by 80
Duff, G. W., & Atkins, E. (1982) · Journal of Immunological Methods · doi:10.1016/0022-1759(82)90004-7 · Cited by 77
Interleukin 1 reduces opioid binding in guinea pig brain
Ahmed, M. S., Llanos, J.-Q., Dinarello, C. A., & Blatteis, C. M. (1985) · Peptides · doi:10.1016/0196-9781(85)90442-5 · Cited by 63
Self-citationProstaglandin E2 and fever: a continuing debate.
Coceani, F., Bishai, I., Lees, J., & Sirko, S. (1986) · PubMed Central · Cited by 43
Thromboxane, prostacyclin, and the hemodynamic effects of graded bacteremic shock.
Slotman, G. J., Quinn, J., Burchard, K. W., & Gann, D. S. (1985) · PubMed · Cited by 36
Venezio, F. R., DiVincenzo, C. A., Pearlman, F., & Phair, J. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/152.4.690 · Cited by 34
Infection, inflammation, and interleukin 1 (IL-1).
Rf, K. (1983) · PubMed · Cited by 34
Experimental Bacteroides fragilis Bacteremia in a Primate Model
SIMON, G. L., Gelfand, J. A., Connolly, R. J., O’Donnell, T. F. X., & Gorbach, S. L. (1985) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-198512000-00007 · Cited by 22
Self-citationTreatment of experimental canine endotoxin shock with ibuprofen, a cyclooxygenase inhibitor.
Pm, A., KUENZIG, M. C., & Schwartz, S. I. (1984) · PubMed · Cited by 21
Implications for thromboxane A2 in the pathogenesis of endotoxic shock.
Wise, W. C., Cook, J. A., & Halushka, P. V. (1981) · PubMed · Cited by 19
Cited by
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Self-citationEndres, S., Ghorbani, R., Kelley, V. E., Georgilis, K., Lonnemann, G., van der Meer, J. W. M., Cannon, J. G., Rogers, T. S., Klempner, M. S., Weber, P. C., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902023200501 · Cited by 1,910
Self-citationTyrosine Kinase Inhibition: An Approach to Drug Development
Levitzki, A., & Gazit, A. (1995) · Science · doi:10.1126/science.7892601 · Cited by 1,635
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
“whereas other cytokines may have inhibitory effects indicating the complex nature of the host response (3-5).”
Metadata
- Authors
- Okusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J., & Dinarello, C. A.
- Venue
- Journal of Clinical Investigation
- Published
- 1988-04-01
- Volume
- 81
- Issue
- 4
- Pages
- 1162-1172
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2166542918
- Cited by
- 983
- References
- 39
- FWCI
- 56.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.